Prostate Cancer Risk Categories

Prostate Cancer Risk Categories

Anthony D’Amico, MD, PhD, Chief, Genitourinary Radiation Oncology at Dana-Farber/Brigham and Women’s Cancer Center, discusses why determining a prostate cancer patient’s risk level is critical to determining the appropriate prostate cancer therapy.

Prostate cancer is the second most common and deadly cancer among American men. About 1 in 6 men will be diagnosed with prostate cancer during their lifetime, and about 1 in 33 men will die from the disease. Yet, despite the disease’s potential dangers, many men diagnosed with prostate cancer shouldn’t be treated aggressively, and others shouldn’t be treated at all – but still be closely monitored. 


Created by

Brigham and Women's Physician Resource Center

Related Presenters

Anthony D'Amico, MD, PhD

Anthony D'Amico, MD, PhD

Chief, Division of Genitourinary Radiation Oncology

Dr. Anthony D'Amico is a professor of Radiation Oncology at Harvard Medical School and is the chief of Genitourinary Radiation Oncology at the Brigham and Women's Hospital and Dana-Farber Cancer Institute. He received his PhD in Radiation ...